Chimeric antibodies blend murine variable regions with human constant domains. Biointron explains their design, benefits, and role in modern therapeutics.
Chimeric antibodies marked a milestone in drug development. Biointron reviews their creation and impact as a foundation for today’s therapeutic antibodies.
You can also contact us on the Scientist and Science Exchange marketplaces.
Our website uses cookies to improve your experience. Read our Privacy Policy to find out more.
